Explore Clinical Trials

Our pipeline includes the Exelixis-discovered compounds, cabozantinib and zanzalintinib, as well as other programs that are the subject of partnerships and collaborations with several biopharmaceutical companies. The safety and efficacy of these investigational compounds and/or investigational uses of approved products have not been established. This information is presented only for purposes of providing a general overview of clinical trials and should not be construed as a recommendation for use of any compound or product for unapproved uses.

Pipeline

Molecular structures below are artistic renderings.

{{ product_data.name_display }}

{{ product_data.description }}

View trials

View trials for all compounds

Filter Trials by

Clear Filters

Compound

Selected /

{{ product }}

Cancer Type

Selected /

{{ upper(oncology_area) }}

Key Program

Selected /

{{ upper(keyprogram) }}

Trial phase

Selected /

Phase {{ phase }}

View trials
({{ matches }} matches)

Filter Trials by

Abbreviations

No trials found with that criteria.

{{ upper(group.oncology_area) }}

Phase {{ trial.phase}}

{{ trial.tumour_type}}

{{ trial.study_number}}

{{ trial.treatment_arms_card}}

{{ trial.status }}